Please assess the completion status of the following clinical trial:

Trial Title: Development of Positive Psychotherapy for Smoking Cessation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* smoke at least 5 cigarettes per day for longer than one year with no other ongoing tobacco product use~* willing to use the transdermal nicotine patch~* report at least a 5 on a 0 to 10 scale rating the importance of quitting smoking.~Exclusion Criteria:~* are currently experiencing psychotic symptoms, affective disorder (major depression, dysthymia, or mania) or substance use disorder (other than nicotine dependence)~* taking prescribed psychotropic medication or receiving other forms of psychotherapy~* concomitantly using other pharmacotherapies for smoking cessation~* have any contraindications for use of the transdermal nicotine patch.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Positive psychotherapy (Type: EXPERIMENTAL): 6 sessions of individual behavioral smoking cessation counseling that incorporates techniques from Positive Psychotherapy to increase positive affect and reduce negative affect prior to and after quitting smoking. Intervention includes 8 weeks of transdermal nicotine patch.
- Standard treatment (Type: ACTIVE_COMPARATOR): 6 sessions of individual behavioral smoking cessation counseling with 8 weeks of transdermal nicotine patch. Inlcudes relaxation training to match time in the experimental condition

Based on this trial design, predict the completion outcome and termination type (if applicable).